within Pharmacolibrary.Drugs.B_BloodAndBloodFormingOrgans.B06A_OtherHematologicalAgents.B06AA02_FibrinolysinAndDesoxyribonuclease;
model FibrinolysinAndDesoxyribonuclease 
   extends Pharmacolibrary.Drugs.ATC.B.B06AA02;

  annotation(Documentation(
    info ="<html><body><p>Fibrinolysin and desoxyribonuclease is a combination drug containing the proteolytic enzyme fibrinolysin and the enzyme deoxyribonuclease (DNase). It was primarily used for topical application to remove dead tissue in wounds, ulcers, burns, and other lesions, facilitating wound healing. The drug has been largely discontinued and is not approved or widely used in contemporary medicine.</p><h4>Pharmacokinetics</h4><p>No published pharmacokinetic studies exist for the topical or systemic use of fibrinolysin and desoxyribonuclease, as systemic absorption is negligible when used as indicated (topical/local application).</p><h4>References</h4><ol></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>",
    experiment(StartTime = 0, StopTime = 86400, Tolerance = 1e-09, Interval = 1)
  ));  
end FibrinolysinAndDesoxyribonuclease;
